Cargando…
Bioactive glass S53P4 vs. autologous bone graft for filling defects in patients with chronic osteomyelitis and infected non-unions – a single center experience
Introduction: The goals of osteomyelitis therapy are successful control of infection and reconstruction of the bone. The gold standard for filling defects is the autologous bone graft. Bioactive glass S53P4 is an inorganic bone substitute. We compared the outcome of using bioactive glass (BAG) versu...
Autores principales: | Steinhausen, Eva, Lefering, Rolf, Glombitza, Martin, Brinkmann, Nikolaus, Vogel, Carsten, Mester, Bastian, Dudda, Marcel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Copernicus GmbH
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8132459/ https://www.ncbi.nlm.nih.gov/pubmed/34084694 http://dx.doi.org/10.5194/jbji-6-73-2021 |
Ejemplares similares
-
Reply to McNally's comment on “Bioactive glass S53P4 vs. autologous bone graft for filling defects in patients with chronic osteomyelitis and infected non-unions – a single center experience” by Steinhausen et al. (2021)
por: Steinhausen, Eva, et al.
Publicado: (2021) -
C-Nail versus plate osteosynthesis in displaced intra-articular calcaneal fractures—a comparative retrospective study
por: Steinhausen, Eva, et al.
Publicado: (2021) -
Comment on “Bioactive glass S53P4 vs. autologous bone graft for filling defects in patients with chronic osteomyelitis and infected non-unions – a single center experience” by Steinhausen et al. (2021)
por: McNally, Martin
Publicado: (2021) -
Mid-term clinical results of chronic cavitary long bone osteomyelitis treatment using S53P4 bioactive glass: a multi-center study
por: Van Vugt, Tom A. G., et al.
Publicado: (2021) -
S53P4 BIOACTIVE GLASS PUTTY IN THE LOCAL TREATMENT OF CAVITARY CHRONIC OSTEOMYELITIS
por: REIS, GABRIELA NAGY BALDY DOS, et al.
Publicado: (2023)